We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.57B
AUM Growth
+$536M
Cap. Flow
+$353M
Cap. Flow %
5.37%
Top 10 Hldgs %
20.82%
Holding
665
New
181
Increased
125
Reduced
203
Closed
118
Avg Time Held
1.5 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.7 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$103M
2
AAPL icon
Apple
AAPL
+$72.7M
3
PRE icon
PARTNERRE LTD
PRE
+$72.6M
4
ESRX
Express Scripts Holding Company
ESRX
+$71.7M
5
EG icon
Everest Group
EG
+$67.3M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$61.5M
2
AZO icon
AutoZone
AZO
+$57.7M
3
SYY icon
Sysco
SYY
+$44.3M
4
TGT icon
Target
TGT
+$41.7M
5
CSCO icon
Cisco
CSCO
+$35.4M

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.41%
2 Healthcare 17.87%
3 Financials 11.74%
4 Technology 9.35%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
T icon
1
AT&T
T
$157B
$183M 2.79%
6,912,106
+1,706,991
+33% +$42.9M
2013 Q2
3 quarters
WMT icon
2
Walmart Inc
WMT
$891B
$168M 2.56%
6,598,410
-55,335
-0.8% -$1.39M
2013 Q2
3 quarters
VZ icon
3
Verizon
VZ
$181B
$156M 2.37%
3,273,723
+1,012,148
+45% +$47.9M
2013 Q2
3 quarters
TSN icon
4
Tyson Foods
TSN
$18.9B
$146M 2.23%
3,328,603
+828,438
+33% +$31.4M
2013 Q2
3 quarters
MRK icon
5
Merck
MRK
$350B
$129M 1.96%
2,376,587
+1,987,799
+511% +$103M
2013 Q2
3 quarters
CLX icon
6
Clorox
CLX
$10.2B
$128M 1.95%
1,459,380
-12,865
-0.9% -$1.13M
2013 Q2
3 quarters
CVX icon
7
Chevron
CVX
$427B
$126M 1.92%
1,061,414
+1,886
+0.2% +$219K
2013 Q2
3 quarters
USB icon
8
US Bancorp
USB
$88.6B
$116M 1.76%
2,697,977
-99,474
-4% -$4.09M
2013 Q2
3 quarters
IBM icon
9
IBM
IBM
$217B
$114M 1.74%
621,803
-47,982
-7% -$8.45M
2013 Q2
3 quarters
JNJ icon
10
Johnson & Johnson
JNJ
$599B
$102M 1.55%
1,035,206
+10,670
+1% +$989K
2013 Q2
3 quarters
AAPL icon
11
Apple
AAPL
$4.98T
$99.2M 1.51%
5,174,904
+3,821,132
+282% +$72.7M
2013 Q2
3 quarters
MCK icon
12
McKesson
MCK
$112B
$97.1M 1.48%
549,824
-55,186
-9% -$9.64M
2013 Q2
3 quarters
DGX icon
13
Quest Diagnostics
DGX
$25.4B
$95.8M 1.46%
1,653,728
+680,986
+70% +$36.5M
2013 Q4
1 quarter
PEP icon
14
PepsiCo
PEP
$173B
$93.3M 1.42%
1,117,386
-39,180
-3% -$3.18M
2013 Q2
3 quarters
EIX icon
15
Edison International
EIX
$21.3B
$86M 1.31%
1,519,901
-283,162
-16% -$14.1M
2013 Q2
3 quarters
COR icon
16
Cencora
COR
$63B
$85.1M 1.29%
1,297,359
-508,492
-28% -$34.6M
2013 Q2
3 quarters
LH icon
17
Labcorp
LH
$25.4B
$84.6M 1.29%
1,002,278
-18,950
-2% -$1.51M
2013 Q3
2 quarters
PFE icon
18
Pfizer
PFE
$162B
$75.8M 1.15%
2,488,063
-982,447
-28% -$29.3M
2013 Q2
3 quarters
PRE icon
19
DELISTED
PARTNERRE LTD
PRE
$75.3M 1.14%
+727,121
New +$72.6M
2014 Q1
0 quarters
GIS icon
20
General Mills
GIS
$17B
$74.5M 1.13%
1,438,636
-98,374
-6% -$4.87M
2013 Q2
3 quarters
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
$73.1M 1.11%
973,836
+958,158
+6,111% +$71.7M
2013 Q4
1 quarter
HSY icon
22
Hershey
HSY
$32.8B
$72.1M 1.1%
691,083
-169,532
-20% -$17.3M
2013 Q2
3 quarters
RCI icon
23
Rogers Communications
RCI
$16.6B
$70.4M 1.07%
1,696,589
+427,300
+34% +$17.4M
2013 Q2
3 quarters
EG icon
24
Everest Group
EG
$14.4B
$69.8M 1.06%
+455,765
New +$67.3M
2014 Q1
0 quarters
LLY icon
25
Eli Lilly
LLY
$1.04T
$68.4M 1.04%
1,162,699
-408,414
-26% -$22.8M
2013 Q2
3 quarters
1
2 3 4 5

Similar funds

JHC
JFB Holdings Corp Atlanta, Georgia $3.13B AUM 14.67% 1-Year Est. Return
SAMC
Shinko Asset Management Company Tokyo, Japan $14.7B AUM 18.14% 1-Year Est. Return
EDRAMF
Edmond de Rothschild Asset Management (France) Paris, France $2.3B AUM 15.71% 1-Year Est. Return
PRA
Parametric Risk Advisors Westport, Connecticut $1.48B AUM 25% 1-Year Est. Return
TH
TMFS Holdings Overland Park, Kansas $1.2B AUM 9.33% 1-Year Est. Return
GF
Gerstein Fisher New York $811M AUM 13.96% 1-Year Est. Return
ACN
Advisor Consultant Network Cleveland, Ohio $705M AUM
GAIA
Global Atlantic Investment Advisors Indianapolis, Indiana $678M AUM 9.05% 1-Year Est. Return

Analytic Investors's Q1 2014 Portfolio in Review

As of Q1 2014, Analytic Investors held 665 positions worth $6.57B, up 8.9% from $6.04B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Analytic Investors deployed $353M of net new capital in Q1 2014, opening 181 new positions and adding to 125 existing holdings. Its largest new stake was PARTNERRE LTD: 727,121 shares worth $75.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $61.5M trimmed.

  • Analytic Investors's largest Q1 2014 buy was PARTNERRE LTD: 727,121 shares worth $75.3M.
  • Analytic Investors added most to Merck in Q1 2014, an estimated $103M increase.
  • Analytic Investors's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $61.5M.
  • Analytic Investors fully exited Oracle in Q1 2014, selling an estimated $29.2M.
  • Analytic Investors's ten largest holdings make up 21% of its $6.57B portfolio in Q1 2014.
  • Analytic Investors opened 181 new positions and closed 118 in Q1 2014.
  • Analytic Investors's portfolio value rose 8.9% quarter-over-quarter to $6.57B.

Based on Analytic Investors's 13F filing for Q1 2014, filed 12 May 2014.